Department of Neuroscience and Pharmacology, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Fraternal Order of Eagles Diabetes Research Center, Carver College of Medicine, University of Iowa, Iowa City, Iowa.
Am J Physiol Heart Circ Physiol. 2021 Nov 1;321(5):H850-H864. doi: 10.1152/ajpheart.00419.2021. Epub 2021 Sep 3.
Molecular mechanisms underlying cardiac dysfunction and subsequent heart failure in diabetic cardiomyopathy are incompletely understood. Initially we intended to test the role of G protein-coupled receptor kinase 2 (GRK2), a potential mediator of cardiac dysfunction in diabetic cardiomyopathy, but found that control animals on HFD did not develop cardiomyopathy. Cardiac function was preserved in both wild-type and knockout animals fed high-fat diet as indicated by preserved left ventricular ejection fraction (LVEF) although heart mass was increased. The absence of cardiac dysfunction led us to rigorously evaluate the utility of diet-induced obesity to model diabetic cardiomyopathy in mice. Using pure C57BL/6J animals and various diets formulated with different sources of fat-lard (32% saturated fat, 68% unsaturated fat) or hydrogenated coconut oil (95% saturated fat), we consistently observed left ventricular hypertrophy, preserved LVEF, and preserved contractility measured by invasive hemodynamics in animals fed high-fat diet. Gene expression patterns that characterize pathological hypertrophy were not induced, but a modest induction of various collagen isoforms and matrix metalloproteinases was observed in heart with high-fat diet feeding. PPARα-target genes that enhance lipid utilization such as , , , and were induced, but mitochondrial energetics was not impaired. These results suggest that although long-term fat feeding in mice induces cardiac hypertrophy and increases cardiac fatty acid metabolism, it may not be sufficient to activate pathological hypertrophic mechanisms that impair cardiac function or induce cardiac fibrosis. Thus, additional factors that are currently not understood may contribute to the cardiac abnormalities previously reported by many groups. Dietary fat overload (DFO) is widely used to model diabetic cardiomyopathy but the utility of this model is controversial. We comprehensively characterized cardiac contractile and mitochondrial function in C57BL6/J mice fed with lard-based or saturated fat-enriched diets initiated at two ages. Despite cardiac hypertrophy, contractile and mitochondrial function is preserved, and molecular adaptations likely limit lipotoxicity. The resilience of these hearts to DFO underscores the need to develop robust alternative models of diabetic cardiomyopathy.
糖尿病心肌病中心功能障碍和随后心力衰竭的分子机制尚不完全清楚。最初,我们打算测试 G 蛋白偶联受体激酶 2 (GRK2) 的作用,GRK2 是糖尿病心肌病中心功能障碍的潜在介质,但发现高脂肪饮食喂养的对照动物没有发展为心肌病。尽管心脏质量增加,但高脂肪饮食喂养的野生型和基因敲除动物的心脏功能均得到保留,左心室射血分数 (LVEF) 保留。由于没有心脏功能障碍,我们严格评估了饮食诱导肥胖在小鼠糖尿病心肌病模型中的应用。使用纯 C57BL/6J 动物和不同脂肪来源的各种饮食(猪油,32%饱和脂肪,68%不饱和脂肪或氢化椰子油,95%饱和脂肪),我们始终观察到喂食高脂肪饮食的动物出现左心室肥大、LVEF 保留和收缩性保留,通过侵入性血液动力学测量。没有诱导出特征病理性肥大的基因表达模式,但在高脂肪饮食喂养的心脏中观察到各种胶原蛋白同工型和基质金属蛋白酶的适度诱导。增强脂质利用的 PPARα 靶基因,如、、和被诱导,但线粒体能量代谢没有受损。这些结果表明,尽管小鼠的长期脂肪喂养会引起心脏肥大并增加心脏脂肪酸代谢,但这可能不足以激活损害心脏功能或诱导心脏纤维化的病理性肥大机制。因此,目前尚不清楚的其他因素可能导致许多研究小组之前报道的心脏异常。饮食性脂肪过载 (DFO) 广泛用于模拟糖尿病性心肌病,但该模型的实用性存在争议。我们全面描述了在两个年龄段开始用猪油或富含饱和脂肪的饮食喂养的 C57BL6/J 小鼠的心脏收缩和线粒体功能。尽管存在心脏肥大,但收缩和线粒体功能得到保留,分子适应可能限制脂肪毒性。这些心脏对 DFO 的抵抗力强调需要开发更稳健的糖尿病性心肌病替代模型。